{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T14:20:50Z","timestamp":1782138050575,"version":"3.54.5"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13023-017-0589-1","type":"journal-article","created":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T14:02:44Z","timestamp":1487080964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Neurological outcome of patients with cryopyrin-associated periodic syndrome (CAPS)"],"prefix":"10.1186","volume":"12","author":[{"given":"Nafissa","family":"Mamoudjy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Maurey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Marie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Kon\u00e9-Paut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumaran","family":"Deiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,14]]},"reference":[{"issue":"3","key":"589_CR1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/ard.2010.138420","volume":"70","author":"L Cuisset","year":"2011","unstructured":"Cuisset L, Jeru I, Dumont B, Fabre A, Cochet E, Le Bozec J, Delpech M, Amselem S, Touitou I. French Csg: Mutations in the autoinflammatory cryopyrin-associated periodic syndrome gene: epidemiological study and lessons from eight years of genetic analysis in France. Ann Rheum Dis. 2011;70(3):495\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"589_CR2","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/ng756","volume":"29","author":"HM Hoffman","year":"2001","unstructured":"Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet. 2001;29(3):301\u20135.","journal-title":"Nat Genet"},{"key":"589_CR3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-med-061512-150641","volume":"65","author":"AA Jesus","year":"2014","unstructured":"Jesus AA, Goldbach-Mansky R. IL-1 blockade in autoinflammatory syndromes. Annu Rev Med. 2014;65:223\u201344.","journal-title":"Annu Rev Med"},{"issue":"23","key":"589_CR4","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa0810787","volume":"360","author":"HJ Lachmann","year":"2009","unstructured":"Lachmann HJ, Kone-Paut I, Kuemmerle-Deschner JB, Leslie KS, Hachulla E, Quartier P, Gitton X, Widmer A, Patel N, Hawkins PN, et al. Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med. 2009;360(23):2416\u201325.","journal-title":"N Engl J Med"},{"key":"589_CR5","first-page":"235","volume":"31","author":"TJ Muckle","year":"1962","unstructured":"Muckle TJ. Wellsm: Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome. Q J Med. 1962;31:235\u201348.","journal-title":"Q J Med"},{"issue":"6","key":"589_CR6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJMoa055137","volume":"355","author":"R Goldbach-Mansky","year":"2006","unstructured":"Goldbach-Mansky R, Dailey NJ, Canna SW, Gelabert A, Jones J, Rubin BI, Kim HJ, Brewer C, Zalewski C, Wiggs E, et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med. 2006;355(6):581\u201392.","journal-title":"N Engl J Med"},{"issue":"4","key":"589_CR7","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1067\/mai.2001.118790","volume":"108","author":"HM Hoffman","year":"2001","unstructured":"Hoffman HM, Wanderer AA, Broide DH. Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever. J Allergy Clin Immunol. 2001;108(4):615\u201320.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"589_CR8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.revmed.2014.10.006","volume":"36","author":"I Kone-Paut","year":"2015","unstructured":"Kone-Paut I. Cryopyrine-associated periodic syndrome: CAPS seen from adulthood. Rev Med Interne. 2015;36(4):277\u201382.","journal-title":"Rev Med Interne"},{"issue":"11","key":"589_CR9","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1136\/annrheumdis-2013-204991","volume":"74","author":"R Levy","year":"2015","unstructured":"Levy R, Gerard L, Kuemmerle-Deschner J, Lachmann HJ, Kone-Paut I, Cantarini L, Woo P, Naselli A, Bader-Meunier B, Insalaco A, et al. Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome: a series of 136 patients from the Eurofever Registry. Ann Rheum Dis. 2015;74(11):2043\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"589_CR10","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/rheumatology\/kep321","volume":"48","author":"S Compeyrot-Lacassagne","year":"2009","unstructured":"Compeyrot-Lacassagne S, Tran TA, Guillaume-Czitrom S, Marie I, Kone-Paut I. Brain multiple sclerosis-like lesions in a patient with Muckle-Wells syndrome. Rheumatology (Oxford). 2009;48(12):1618\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"16","key":"589_CR11","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1212\/WNL.0b013e3181d9ed69","volume":"74","author":"JL Kitley","year":"2010","unstructured":"Kitley JL, Lachmann HJ, Pinto A, Ginsberg L. Neurologic manifestations of the cryopyrin-associated periodic syndrome. Neurology. 2010;74(16):1267\u201370.","journal-title":"Neurology"},{"issue":"7","key":"589_CR12","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/j.1526-4610.2005.05135.x","volume":"45","author":"F Perini","year":"2005","unstructured":"Perini F, D'Andrea G, Galloni E, Pignatelli F, Billo G, Alba S, Bussone G, Toso V. Plasma cytokine levels in migraineurs and controls. Headache. 2005;45(7):926\u201331.","journal-title":"Headache"},{"issue":"4","key":"589_CR13","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/rheumatology\/kel399","volume":"46","author":"T Lequerre","year":"2007","unstructured":"Lequerre T, Vittecoq O, Saugier-Veber P, Goldenberg A, Patoz P, Frebourg T, Le Loet X. A cryopyrin-associated periodic syndrome with joint destruction. Rheumatology (Oxford). 2007;46(4):709\u201314.","journal-title":"Rheumatology (Oxford)"},{"key":"589_CR14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1750-1326-9-56","volume":"9","author":"S Rossi","year":"2014","unstructured":"Rossi S, Motta C, Studer V, Macchiarulo G, Volpe E, Barbieri F, Ruocco G, Buttari F, Finardi A, Mancino R, et al. Interleukin-1beta causes excitotoxic neurodegeneration and multiple sclerosis disease progression by activating the apoptotic protein p53. Mol Neurodegener. 2014;9:56.","journal-title":"Mol Neurodegener"},{"key":"589_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-11-1","volume":"11","author":"N Singh","year":"2014","unstructured":"Singh N, Hopkins SJ, Hulme S, Galea JP, Hoadley M, Vail A, Hutchinson PJ, Grainger S, Rothwell NJ, King AT, et al. The effect of intravenous interleukin-1 receptor antagonist on inflammatory mediators in cerebrospinal fluid after subarachnoid haemorrhage: a phase II randomised controlled trial. J Neuroinflammation. 2014;11:1.","journal-title":"J Neuroinflammation"},{"issue":"8","key":"589_CR16","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.3899\/jrheum.131291","volume":"41","author":"C Marsaud","year":"2014","unstructured":"Marsaud C, Marie I, Kone-Paut I. Longterm followup of quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab, an anti-interleukin 1beta monoclonal antibody. J Rheumatol. 2014;41(8):1721\u20132.","journal-title":"J Rheumatol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-017-0589-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T10:30:43Z","timestamp":1498386643000},"score":1,"resource":{"primary":{"URL":"http:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-017-0589-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,14]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["589"],"URL":"https:\/\/doi.org\/10.1186\/s13023-017-0589-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,14]]},"article-number":"33"}}